The influenza virus belongs to the family Orthomyxoviridae and has three types: A, B, and C. Infection by the influenza A virus is the most common and severe and is generally found in humans. It spreads rapidly, affecting human populations across large geographical regions within a short period of time, with varying degrees of pathology ranging from mild to severe. Wild aquatic birds and other animals, such as pigs, ferrets, horses, seals, whales, mink, anteaters, cats, and dogs, serve as reservoirs for influenza A viruses. Influenza B and C viruses have a very limited host range and predominantly appear in humans.

The influenza virus gains pandemic potential through genetic reassortment, called a "genetic shift," which involves the complete renewal of surface antigens. Additionally, the virus undergoes small but gradual genetic changes through mutations, which allow it to adapt efficiently to the human population, a process known as "genetic drift." Although the epidemiology of influenza infection has been studied for several years, some facts about disease transmission are poorly understood.

Animal models are essential for studying the pathogenesis of influenza virus infections and developing and evaluating influenza vaccines. Commonly used models include mice, ferrets, pigs, rabbits, dogs, and non-human primates. Mouse and ferret models are widely used in influenza virus research. For example, they are used in preclinical studies to evaluate the safety, immunogenicity, and efficacy of candidate influenza vaccines, as well as to screen antiviral compounds.

Creative Diagnostics specializes in providing mouse models for influenza A virus infection. These models can enable a comprehensive evaluation of the effects of test compounds on the pathogenicity and transmissibility of influenza A strains, which offer scientists insights into virus-host interactions, aiding them in elucidating transmission dynamics and the impact of influenza A on morbidity and mortality. Additionally, these influenza A mouse models help researchers evaluate various therapeutic agents, such as antiviral drugs, anti-inflammatory medications, and pulmonary treatments.

Creative Diagnostics' research team studies multiple influenza A strains, including H9N2, H1N1, and H3N2. The company offers clients a portfolio of customized and standardized preclinical services utilizing mouse infection models to evaluate pathogenic mechanisms, humoral immune responses, and protective efficacy induced by wild-type influenza A viruses or influenza vaccines. The mouse models include H9N2 Avian Influenza Mouse Model, H1N1 Strain Mouse Model, Pdm H1N1 Strain Mouse Model, and H3N2 Strain Mouse Model.

Creative Diagnostics offers a diverse range of carefully selected and bred mouse strains for influenza A virus research. With this extensive selection, researchers can choose the most suitable model to address their specific research questions. For more information on these models or related innovative solutions for preclinical research involving infectious diseases, please visit https://antiviral.creative-diagnostics.com/influenza-a-virus-mouse-model.html.

About Creative Diagnostics

Headquartered in New York, Creative Diagnostics is a consulting and experimental service provider specializing in virology and microbiology. The company provides comprehensive solutions to conquer obstacles in virology and microbiology research, from high-security infrastructure provision, biosafety regulation elucidation, to expert viral system assistance.